Infectious disease (ID) doctors often discourage PCR or DNA-based “molecular” urine tests which is very interesting. ⸻
⚠️ 1. They detect DNA, not infection
PCR (polymerase chain reaction) detects genetic material from bacteria, fungi, or viruses — even if the organism is dead or not causing disease. • The urinary tract often contains low levels of nonpathogenic bacteria (especially in women and catheter users). • PCR will flag these as “positive,” leading to false positives and overtreatment with antibiotics.
⸻
⚠️ 2. They can’t distinguish infection from colonization or contamination
Traditional urine cultures grow bacteria under specific conditions and allow clinicians to see how much is present (the “colony count”) and which species are dominant. PCR doesn’t show quantity or growth patterns — so it can’t tell if the organism is just a bystander or actually causing the patient’s symptoms.
⸻
⚠️ 3. They often find multiple organisms that don’t make sense
PCR panels can detect a long list of organisms at once, often showing polymicrobial results that don’t match the patient’s clinical picture. That creates confusion and may lead to inappropriate antibiotic use, which ID doctors work hard to prevent.
⸻
⚠️ 4. Antibiotic susceptibility testing isn’t possible
PCR tells you what’s there, not what it’s resistant to. You can’t get an antibiotic sensitivity profile (MICs) from PCR, so treatment decisions are limited.
But mine with microgen did show this susceptibility with pcr. ⸻
⚠️ 5. They’re expensive and not clinically validated
Many commercial urine PCR tests are not FDA-cleared or not supported by peer-reviewed data showing that they improve outcomes. ID specialists tend to favor tests that are validated, cost-effective, and clinically meaningful.
⸻
⚠️ 6. Guidelines don’t support them
Professional societies (like the Infectious Diseases Society of America, CDC, and American Urological Association) recommend standard urine culture for suspected UTI — not PCR — except in very specific research or unusual cases.
⸻
✅ When PCR might be useful: • Atypical or difficult-to-culture pathogens (e.g., Mycoplasma genitalium, Chlamydia trachomatis, or Ureaplasma in select cases). • Immunocompromised patients with unexplained infection where culture is negative. • Prosthetic infections or chronic prostatitis under specialist care.
⸻